Atria Investments Inc Sells 2,987 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Atria Investments Inc decreased its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 22.9% in the fourth quarter, Holdings Channel reports. The fund owned 10,078 shares of the biopharmaceutical company’s stock after selling 2,987 shares during the quarter. Atria Investments Inc’s holdings in Halozyme Therapeutics were worth $482,000 at the end of the […]
Atria Investments Inc decreased its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 22.9% in the fourth quarter, Holdings Channel reports. The fund owned 10,078 shares of the biopharmaceutical company’s stock after selling 2,987 shares during the quarter. Atria Investments Inc’s holdings in Halozyme Therapeutics were worth $482,000 at the end of the […]
